Sanjing Pharma Says Chairman Jumps to Death During Probe
This article is for subscribers only.
The chairman of Harbin Pharmaceutical Group Sanjing Pharmaceutical Co. jumped to his death while being investigated for corruption amid a nationwide crackdown on graft by officials and company executives.
Liu Zhanbin leapt out of a third-floor hospital restroom on May 18 in Heihe, a city on China’s northern border with Russia, while receiving a health check-up, the Chinese generic drugmaker said in a statement yesterday, citing prosecutors. He was being investigated by officials in the city for suspected graft, the official Xinhua News Agency reported.